Full Release MINNEAPOLIS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc . (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today the presentation of new real-world evidence at the Technology and Heart Failure Therapeutics (THT) conference in Boston....
Orchestra BioMed Holdings, Inc. announced promising echocardiographic data regarding atrioventricular interval modulation (AVIM) therapy's impact on patients with diastolic dysfunction at the THT 2025 Conference. The analysis from the MODERATO II study revealed that AVIM therapy significantly impr...
perform and get certified on Siemens Software Events Global Conferences Find a Global Conference EDA Events EDA Events & Webinars Partners Partners Network, programs and application Partner Finder Locator, descriptions and contacts How to Buy Buying with Siemens Buy online Partners Academics Renewals Refu...
THT senior management will host a conference call onTuesday, May 15, 2012at8:00 a.m.(Eastern) /5:00 a.m.(Pacific) /8:00 p.m.(Beijing/Hong Kong) to discuss the Company's first quarter 2012 financial results and recent business activity. The conference call may be accessed by calling...
Rooted in a deep understanding of the importance of customer satisfaction, TITAN is dedicated to delivering cutting-edge technology solutions tailored to the unique needs of our clients in the Commercial Sector. From state-of-the-art Conference Room technologies to comprehensive Hospitality Technology so...
Delegates Event TypeConference Editions Jan 2025 InterestedFrequency Newly Listed Official Links WebsiteContacts Report ErrorClaim this event Organizer Request a Booth Queries about the event? Ask Organizer PlugVolt USA12 Total Events Venue Map & Directions Venue to be announced Online Add Venue ...
, from the 2023 Technology and Heart Failure Therapeutics Conference. The full-length session focuses on the unique physiological effects of counterpulsation in advanced heart failure patients. Moreover, the session provides guidance on MCS selection based on underlying etiology, clinical phe...
(Nasdaq: DXR), the global leader in blood volume measurement technology, announces groundbreaking new studies fromDuke University Medical CenterandYale School of Medicine, presented at theTechnology and Heart Failure Therapeutics Conference(THT). Held fromFebruary 11-13, 2025, at theO...